Form 483

Omega & Delta Co., Inc. Form 483, 2011-09-20

FDA issued a Form 483 to Omega & Delta Co., Inc. on 2011-09-20 with 7 public-safe observations.

483· Form 483 issued7 observations

Omega & Delta Co., Inc. · Carolina, United States · Issued September 20, 2011

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 Sep 2011
21 CFR 211.25(a)

Training--operations, GMPs, written procedures

Cited by Marilyn Santiago

20 Sep 2011
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Marilyn Santiago

20 Sep 2011
21 CFR 211.67(c)

Cleaning/maintenance records not kept

Cited by Marilyn Santiago

20 Sep 2011
21 CFR 211.84(d)(1)

Identity Testing of Each Component

Cited by Marilyn Santiago

20 Sep 2011
21 CFR 211.94(c)

Containers & Closures Clean, Sterilized, Pyrogen-free

Cited by Marilyn Santiago

Inspected site

O&Omega & Delta Co., Inc.Carolina, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(c)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.94(c)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 7 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere